Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
2 minute read

Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying

By Avi Kapoor
April 12, 8:36 AM
The Dow Jones index closed slightly lower on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

AUGG

Read More
2 minute read

Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data

By Vandana Singh
April 8, 10:02 AM
Palatin Technologies unveils Phase 3 PL9643 MELODY-1 trial results for dry eye disease treatment, showcasing statistically significant efficacy in pain reduction and secondary symptoms. PL9643 demonstrates superior safety and tolerability compared to existing treatments, promising a differentiated solution in the $6.11 billion dry eye disease market.

PTN

Read More
4 minute read

Palatin Provides Corporate Update And Highlights Strategic Priorities For Calendar Year 2024; Completed Asset Sale To Cosette Pharmaceuticals For Up To $171M; $12M Upfront Plus Sales-Based Milestones Of Up To $159M

By Benzinga Newsdesk
January 8, 11:34 AM
Dry Eye Disease (DED): PL9643 MELODY-1 Phase 3 StudyData Base Lock 2H January 2024Topline Data Readout Expected Early 1Q Calendar Year 2024Ulcerative Colitis (UC): Oral PL8177 Phase 2 Clinical Study in Active UC

PTN